B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

POU2F2

MOLECULAR TARGET

POU class 2 homeobox 2

UniProt: P09086NCBI Gene: 54523 compounds

POU2F2 (POU class 2 homeobox 2) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting POU2F2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on0.691
2N-Methylscopolamine0.691
3thiamine0.691

About POU2F2 as a Drug Target

POU2F2 (POU class 2 homeobox 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented POU2F2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

POU2F2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.